Glenmark Pharmaceuticals
GLENMARK.NS
$25.65
Share price
1.97%
Change (1 day)
59.86%
Change (1 year)
Categories
EPS for Glenmark Pharmaceuticals (GLENMARK.NS)
EPS in 2023 (TTM): $0.15
According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.16. In 2022 the company made an earnings per share (EPS) of $0.55 a decrease over its 2021 EPS that were of $0.69.
EPS history for Glenmark Pharmaceuticals from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.15 | -73.06% |
| 2022 | $0.55 | -20.18% |
| 2021 | $0.69 | 7.13% |
| 2020 | $0.65 | 25.72% |
| 2019 | $0.51 | -22.01% |
| 2018 | $0.66 | 30.15% |
| 2017 | $0.51 | -34.82% |
| 2016 | $0.78 | 63.09% |
| 2015 | $0.48 | 9.68% |
| 2014 | $0.43 | -26.58% |
| 2013 | $0.59 | 0.51% |
| 2012 | $0.59 |